准骨髓氧化酶以减少X关联的 dystonia 帕金森症的神经炎症
medRxiv : the preprint server for health sciences
|July 9, 2024
概括
骨髓氧化酶 (MPO) 活性和反应性氧物种 (ROS) 在 X 相关的 dystonia parkinsonism (XDP) 中升高. 抑制MPO会降低ROS,这表明MPO抑制剂如verdiperstat可以治疗XDP.
科学领域:
- 神经科学是一个神经科学.
- 神经退行性疾病 神经退行性疾病
- 生物化学 生物化学
背景情况:
- 链接到X的 dystonia parkinsonism (XDP) 是一种在菲律宾流行的神经退行性疾病.
- 驱动XDP中神经元损失的精确分子机制尚不清楚.
- 以前的研究表明,XDP死后脑组织中神经炎症和髓氧化酶 (MPO) 的增加.
研究的目的:
- 调查MPO活动的作用及其与XDP病变发生过程中的氧化应激的联系.
- 在XDP模型中评估MPO抑制的治疗潜力.
主要方法:
- 使用新型MPO可激活光剂 (MAFA) 在XDP死后前额皮层 (PFC) 中量化MPO活性.
- 在用XDP PFC.治疗的XDP衍生纤维细胞和细胞模型中评估了活性氧物种 (ROS) 水平.
- 利用MPO免疫减弱和MPO抑制剂治疗的verdiperstat来评估ROS调节.
主要成果:
- 在XDP PFC中观察到MPO活性显著增加.
- 在XDP细胞模型中检测到高ROS水平.
- 在XDP模型中,MPO免疫减弱和verdiperstat治疗显著降低了ROS水平.
结论:
- 在与XDP相关的氧化应激中,MPO起着重要的作用.
- 抑制MPO有效地减轻ROS,为XDP提供了潜在的治疗途径.
- 维迪珀斯塔特通过减少氧化应激来证明作为XDP的治疗策略具有前景.
相关概念视频
Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522


